The availability of the 750mcg teriparatide injection in Australia has been phased. Currently, distribution are overseen through select clinics and pharmacies, requiring a referral from an physician. Obtaining this therapeutic is dependent on strict guidelines and patient assessment. Despite the early announcement of broader availability, it remain